Rznomics is a South Korean biotechnology company developing RNA-based gene therapies using a trans-splicing ribozyme platform. Its programs are focused primarily on therapeutic…
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Rznomics →Already a subscriber? Sign in
Xcout Intel tracks Rznomics continuously — this profile deepens as new filings, funding, people and hiring data arrive.